Alector, Inc. (ALEC) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Alector reported revenue of $21.0M, down 79.1% from $100.6M the year before. Net income was -$142.9M (a -679.2% net margin), or -$1.39 per diluted share. Operating margin was -741.3%. Operating activities generated -$184.0M of cash, leaving -$184.1M of free cash flow. At fiscal year end, Alector held $293.2M in total assets against $262.6M in total liabilities, including $65.8M of cash and equivalents.
Open the full interactive Alector financials → Quarterly statements, key ratios, valuation history and price charts.
Alector Key Stats
| Share Price | $1.87 |
|---|---|
| Market Cap | $208.0M |
| Revenue YoY Growth | -79.1% |
| 52-Week Range | $1.14 – $3.31 |
| Shares Outstanding | 111.2 million (basic, 2026 Q2) |
Alector Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $21.1M | $207.1M | $133.6M | $97.1M | $100.6M | $21.0M |
| Operating Income | -$195.2M | -$37.4M | -$137.8M | -$151.7M | -$145.0M | -$156.0M |
| Pre-Tax Income | -$190.2M | -$36.3M | -$130.1M | -$125.2M | -$118.9M | -$142.8M |
| Income Tax | — | $0 | $3.3M | $5.2M | $128,000 | $168,000 |
| Net Income | -$190.2M | -$36.3M | -$133.3M | -$130.4M | -$119.0M | -$142.9M |
| Diluted EPS | -$2.45 | -$0.45 | -$1.62 | -$1.56 | -$1.23 | -$1.39 |
Alector Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $3.3M | $6.2M | $1.0M | $3.3M |
| Net Income | -$34.7M | -$37.3M | -$22.9M | -$23.0M |
| Diluted EPS | -$0.34 | -$0.36 | -$0.21 | -$0.21 |
Alector Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $50.0M | $329.2M | $154.3M | $74.6M | $33.0M | $65.8M |
| Current Assets | $421.5M | $749.7M | $726.4M | $565.8M | $424.8M | $266.5M |
| Total Assets | $488.3M | $814.7M | $787.6M | $621.8M | $468.3M | $293.2M |
| Current Liabilities | $68.1M | $139.6M | $93.8M | $177.9M | $125.1M | $69.5M |
| Total Long-Term Debt | — | — | — | — | $10.0M | $10.0M |
| Total Liabilities | $220.7M | $513.9M | $573.2M | $487.7M | $341.5M | $262.6M |
| Shareholders' Equity | $267.5M | $300.7M | $214.4M | $134.2M | $126.8M | $30.6M |
Alector Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$166.7M | $298.6M | -$20.3M | -$184.2M | -$229.9M | -$184.0M |
| Cash From Investing | -$105.1M | -$49.7M | -$159.0M | $101.9M | $107.1M | $196.6M |
| Cash From Financing | $232.1M | $30.3M | $4.5M | $2.5M | $81.5M | $20.2M |
| Free Cash Flow | -$171.8M | $295.3M | -$24.4M | -$186.5M | -$231.2M | -$184.1M |
Figures from Alector's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Alector financials page for every line item.
Alector Company Profile
| Ticker | ALEC |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | South San Francisco, California |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer, smaller reporting company |
| SEC CIK | 0001653087 |
Frequently Asked Questions
What was Alector's revenue in fiscal 2025?
Alector (ALEC) reported revenue of $21.0M for fiscal 2025.
What is Alector's annual revenue history?
Alector's annual revenue by fiscal year: 2020: $21.1M; 2021: $207.1M; 2022: $133.6M; 2023: $97.1M; 2024: $100.6M; 2025: $21.0M.
What was Alector's net income in fiscal 2025?
Alector reported net income of -$142.9M for fiscal 2025.
What was Alector's earnings per share (EPS) in fiscal 2025?
Alector's diluted EPS was -$1.39 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Alector generate in fiscal 2025?
Alector generated -$184.1M of free cash flow in fiscal 2025.
What was Alector's revenue last quarter?
In its most recent reported quarter (2026 Q2), Alector reported revenue of $3.3M.
How much debt does Alector have?
Alector reported $10.0M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Alector are outstanding?
Alector reported a weighted average of 111.2 million basic shares outstanding in 2026 Q2.
What is Alector's market cap?
Based on its latest closing price, Alector (ALEC) has a market capitalization of about $208.0M.
When does Alector's fiscal year end?
Alector's fiscal year end, as registered with the SEC, is December 31.
Where is Alector headquartered?
Alector lists its business address in South San Francisco, California in its SEC filings.
Alector Competitors & Similar Companies
See all 136 Biological Products, (No Diagnostic Substances) companies →